Jane Chung

Insider Reports History

Entity
Individual
Location
C/O Sutro Biopharma, Inc., 310 Utah Ave., Suite 150, South San Francisco, CA
Signature
/s/ Edward C. Albini as attorney-in-fact for Jane Chung
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jane Chung:

Stock Role Class Num Shares Value Price $ Report Date Ownership
SUTRO BIOPHARMA, INC. PRESIDENT AND COO Restricted Stock Units (RSUs) 100K $454K $4.54 Mar 5, 2024 Direct
SUTRO BIOPHARMA, INC. PRESIDENT AND COO Restricted Stock Unit (RSU) 75K $296K $3.95 Dec 1, 2024 Direct
SUTRO BIOPHARMA, INC. PRESIDENT AND COO Common Stock 70.3K $189K $2.69 Dec 1, 2024 Direct
SUTRO BIOPHARMA, INC. PRESIDENT AND COO Restricted Stock Unit (RSU) 15.8K $75.4K $4.79 Mar 4, 2024 Direct
SUTRO BIOPHARMA, INC. PRESIDENT AND COO Stock Option (Right to Buy Common Stock) 50K Mar 5, 2024 Direct
Viracta Therapeutics, Inc. Director Stock Option (Right to Buy) 50K Jun 20, 2024 Direct
SUTRO BIOPHARMA, INC. PRESIDENT AND COO Stock Option (right to buy) 35K Dec 1, 2023 Direct

Insider Reports Filed by Jane Chung

Symbol Company Period Transactions Value $ Form Type Date Filed Role
STRO SUTRO BIOPHARMA, INC. Dec 1, 2024 3 -$24K 4 Dec 3, 2024 PRESIDENT AND COO
STRO SUTRO BIOPHARMA, INC. Aug 9, 2024 3 -$20.9K 4 Aug 13, 2024 PRESIDENT AND COO
VIRX Viracta Therapeutics, Inc. Jun 20, 2024 1 $0 4 Jun 24, 2024 Director
STRO SUTRO BIOPHARMA, INC. Mar 5, 2024 2 $0 4 Mar 7, 2024 PRESIDENT AND COO
STRO SUTRO BIOPHARMA, INC. Mar 4, 2024 3 -$10.6K 4 Mar 6, 2024 PRESIDENT AND COO
STRO SUTRO BIOPHARMA, INC. Mar 1, 2024 3 -$10.1K 4 Mar 5, 2024 PRESIDENT AND COO
STRO SUTRO BIOPHARMA, INC. Dec 1, 2023 2 $0 4 Dec 4, 2023 President and COO
STRO SUTRO BIOPHARMA, INC. Aug 9, 2023 3 -$27.4K 4 Aug 11, 2023 Chief Commercial Officer
VIRX Viracta Therapeutics, Inc. Jun 8, 2023 1 $0 4 Jun 9, 2023 Director
STRO SUTRO BIOPHARMA, INC. Mar 3, 2023 5 -$18.6K 4 Mar 7, 2023 Chief Commercial Officer
VIRX Viracta Therapeutics, Inc. Aug 10, 2022 1 $0 4 Aug 11, 2022 Director
VIRX Viracta Therapeutics, Inc. Aug 10, 2022 0 $0 3 Aug 11, 2022 Director
STRO SUTRO BIOPHARMA, INC. Aug 9, 2022 3 -$42.8K 4 Aug 10, 2022 Chief Commercial Officer
STRO SUTRO BIOPHARMA, INC. Mar 4, 2022 2 $0 4 Mar 7, 2022 Chief Commercial Officer
STRO SUTRO BIOPHARMA, INC. Aug 9, 2021 2 $0 4 Aug 11, 2021 Chief Commercial Officer
STRO SUTRO BIOPHARMA, INC. Aug 9, 2021 0 $0 3 Aug 11, 2021 Chief Commercial Officer